Oregon

Oregon

  • Clinical trials: Leading breakthroughs in cancer research

    Clinical trials: Leading breakthroughs in cancer research

    May 20 is International Clinical Trials Day. Clinical trials are evidence-based studies in people that result in the biggest breakthroughs in cancer research.

    Read Article
  • Woman with pancreatic cancer grateful for personalized immunotherapy

    Woman with pancreatic cancer grateful for personalized immunotherapy

    Florida woman with metastatic pancreatic cancer participates in groundbreaking clinical trial of adoptive cellular therapy only available at Providence Cancer Institute.

    Read Article
  • Studies will evaluate combination therapies for two types of melanoma

    Studies will evaluate combination therapies for two types of melanoma

    Two new clinical trials available at Providence will evaluate whether a combination of medications are effective and safe therapies for people with metastatic melanoma and metastatic uveal melanoma.

    Read Article
  • ×

    Zip Code
    Thank you for subscribing!
    Error - something went wrong!
  • Oregon hosts global immunology conference featuring Providence immuno-oncology research

    Oregon hosts global immunology conference featuring Providence immuno-oncology research

    Researchers of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, will present their latest cancer immunotherapy data at Immunology2022 in May.

    Read Article
  • Protecting your mental health from global stresses

    Protecting your mental health from global stresses

    Providence Chief Executive of Behavior Health Robin Henderson shares how to protect your mental health in the face of global problems.

    Read Article
  • GET THE APP ›
  • New study evaluates immunoradiotherapy treatment for head and neck cancer patients

    New study evaluates immunoradiotherapy treatment for head and neck cancer patients

    Investigator-initiated clinical trial at Providence Cancer Institute to evaluate the safety and efficacy of using a combination of immunotherapy and radiation therapy on tumors.

    Read Article
  • Donate an old bike for Free Bikes 4 Kidz event, April 30

    Donate an old bike for Free Bikes 4 Kidz event, April 30

    You can donate a bike to any one of 23 locations throughout the Portland Metro area, including 11 Providence locations, from 9 a.m. to 1 p.m. on April 30.

    Read Article
  • Living Well with Mantle Cell Lymphoma

    Living Well with Mantle Cell Lymphoma

    Register for a free virtual education event on April 19 for Mantle Cell Lymphoma patients, presented by the Leukemia & Lymphoma Society (LLS) and Providence Cancer Institute of Oregon.

    Read Article
  • FIND A DOCTOR ›
  • Study to evaluate effect of immunotherapy in blood cancer

    Study to evaluate effect of immunotherapy in blood cancer

    A new phase I clinical trial available at Providence Cancer Institute of Oregon will evaluate the efficacy of new immunotherapy designed to modulate the immune system in blood cancer patients.

    Read Article
  • Community events focus on pancreatic cancer research and awareness

    Community events focus on pancreatic cancer research and awareness

    Providence Cancer Institute of Oregon and Pancreatic Cancer Action Network are partnering to promote awareness and research for pancreatic cancer through two community events this April.

    Read Article
  • Three studies concentrate on personalized treatment for colon cancer

    Three studies concentrate on personalized treatment for colon cancer

    Clinical studies focus on finding new ways to treat colorectal cancer, prevent recurrence and improve survival outcomes.

    Read Article
  • Building capacity to build community

    Building capacity to build community

    Local partner Health Share of Oregon is using a St. Joseph Community Partnership Fund grant to create stable housing opportunities for those at risk of homelessness.

    Read Article
  • LEARN MORE
  • Meet Dr. Hagen Kennecke: Following his passion to advance cancer care

    Meet Dr. Hagen Kennecke: Following his passion to advance cancer care

    Providence medical oncologist and medical director of gastrointestinal oncology talks about his career in oncology and his passion for cancer research.

    Read Article
  • Providence remembers Gerry Frank

    Providence remembers Gerry Frank

    Gerry Frank, whose special concern for children launched the The Gerry Frank Center for Children at Providence St. Vincent Medical Center, passed away on Sunday, March 13.

    Read Article
  • FIND A CLINIC ›
  • Providence oncologist raises funds in honor of blood cancer patients

    Providence oncologist raises funds in honor of blood cancer patients

    Providence medical oncologist Dr. Janet Ruzich accepts LLS Man & Woman of the Year nomination and joins philanthropic campaign to raise funds for local blood cancer research.

    Read Article
  • Three studies focus on improving treatments for gastrointestinal cancers

    Three studies focus on improving treatments for gastrointestinal cancers

    People with gallbladder cancer, bile duct cancer or pancreatic cancer may be eligible to participate in new clinical trials available at Providence Cancer Institute of Oregon.

    Read Article
  • Attend virtual education event for gynecologic cancer care

    Attend virtual education event for gynecologic cancer care

    Gynecologic cancer patients and their caregivers are invited to attend a free, virtual education event on March 9.

    Read Article
  • Better Outcomes Thru Bridges (BOB) Programs

    Better Outcomes Thru Bridges (BOB) Programs

    The Better Outcomes thru Bridges (BOB) Programs focus on serving some of our community’s most vulnerable and underserved people.

    Read Article
  • Cancer Moonshot relaunch aligns with Providence initiatives to reduce cancer burden and improve health equity

    Cancer Moonshot relaunch aligns with Providence initiatives to reduce cancer burden and improve health equity

    Providence initiatives in genomic medicine, immunotherapy research and cancer screening support Cancer Moonshot's goal to decrease the death rate from cancer by 50 percent in 25 years.

    Read Article
  • ×

    Zip Code
    Thank you for subscribing!
    Error - something went wrong!
  • Clinical trial aims to help premenopausal women at risk for ovarian cancer

    Clinical trial aims to help premenopausal women at risk for ovarian cancer

    Researchers at Providence Cancer Institute are studying how well two surgical procedures work in reducing the risk of ovarian cancer for women with BRCA1 mutations.

    Read Article
  • loading
    Loading More...